Delivery Order SPE2DX15D2208-SPE2DX23FMCKZ
Award Date 3/31/23
Potential Completion Date 4/3/23
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $22,909.26 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a medication used to treat and prevent blood clots. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a potential value of $2,705.58 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4563702288 ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a potential value of $2,002.90 and a period of performance through February 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the sole awardee on...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit organization. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a completion date of January 26, 2024 and a potential value of $3,173.45. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential value...
- This is a $18,371.82 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG TABLET 60S. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This specific...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB25FY53L, is for the delivery of 4566108771 units of the pharmaceutical product ELIQUIS 5 MG TABLET 60S. The award, made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, has a ceiling value of $12,781.81 and an ultimate completion date of October 16, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major supplier...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $26,986.97 and a performance period through April 4, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $9,388.89 and a period of performance through July 2, 2025. The contract is not set aside and is a part of Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award, with ID SPE2DX15D2101|SPE2DX24F52NE, is for the delivery of ELIQUIS 5 MG TABLET 60S to the U.S. government. The contract, which has a total ceiling value of $59,807.90, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government, including the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is a Delivery Order under an...
- This is a $50,453.38 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,334,278 units of the prescription medication ELIQUIS 5 MG TABLET 60S. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to...
- SPE2DX15D2208Indefinite Delivery Contract
- SPE2DX15D2208-SPE2DX23FMCKZDelivery Order
4560450022 ! ELIQUIS 5 MG TABLET 60S
Posted 3/31/23
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 3/31/23 |